Anand Subash
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anand Subash has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Vishal Rao
Department of Head & Neck Surgical Oncology, HCG Cancer Centre, Bangalore, Karnataka, India
19 shared publications - Abhijeet Singh
Department of Surgical Oncology, AIIMS, Rishikesh, India
10 shared publications Piyush Sinha
Department of Head and Neck Oncology, Medanta Hospital, Lucknow, India
8 shared publications- Piyush Sinha
Department of Head and Neck Oncology, Medanta Hospital, Lucknow, India
7 shared publications - Shalini Thakur
Department of Head and Neck Surgical Oncology and Robotic Surgery, HealthCare Global (HCG) Cancer Centre, Bangalore, Karnataka, India
6 shared publications Abhijeet Singh
Department of Surgical Oncology, AIIMS, Rishikesh, India
5 shared publications
Latest Publications
- 5 August 2023
- Published by Elsevier in Oral Oncology
- Vol. 145, 106539
Submental artery island flap in malignancy of tongue. A reconstructive Dilemma!
- 5 August 2023
- Published by Elsevier in Oral Oncology
- Vol. 145, 106539
Submental artery island flap in malignancy of tongue. A reconstructive Dilemma!
- 13 April 2023
- Published by Elsevier in Oral Oncology
- Vol. 140, 106390
Preoperative prediction model in salvage surgery for oral cavity squamous cell carcinoma: Precision before Assertion
- 13 April 2023
- Published by Elsevier in Oral Oncology
- Vol. 140, 106390
Preoperative prediction model in salvage surgery for oral cavity squamous cell carcinoma: Precision before Assertion
- 10 August 2022
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 114 (10) , 1400-1409
Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study
Background: Transoral robotic surgery (TORS) is an emerging minimally invasive surgical treatment for residual, recurrent, and new primary head and neck cancers in previously irradiated fields, with limited evidence for its oncological effectiveness. Methods: A retrospective observational cohort study of consecutive cases performed in 16 high-volume international centers before August 2018 was conducted (registered at clinicaltrials.gov [NCT04673929] as the RECUT study). Overall survival (OS), disease-free survival, disease-specific survivals (DSS), and local control (LC) were calculated using Kaplan-Meier estimates, with subgroups compared using log-rank tests and Cox proportional hazards modeling for multivariable analysis. Maximally selected rank statistics determined the cut point for closest surgical resection margin based on LC. Results: Data for 278 eligible patients were analyzed, with median follow-up of 38.5 months. Two-year and 5-year outcomes were 69.0% and 62.2% for LC, 71.8% and 49.8% for OS, 47.2% and 35.7% for disease-free survival, and 78.7% and 59.1% for disease-specific survivals. The most discriminating margin cut point was 1.0 mm; the 2-year LC was 80.9% above and 54.2% below or equal to 1.0 mm. Increasing age, current smoking, primary tumor classification, and narrow surgical margins (≤1.0 mm) were statistically significantly associated with lower OS. Hemorrhage with return to theater was seen in 8.1% (n = 22 of 272), and 30-day mortality was 1.8% (n = 5 of 272). At 1 year, 10.8% (n = 21 of 195) used tracheostomies, 33.8% (n = 66 of 195) used gastrostomies, and 66.3% (n = 53 of 80) had maintained or improved normalcy of diet scores. Conclusions: Data from international centers show TORS to treat head and neck cancers in previously irradiated fields yields favorable outcomes for LC and survival. Where feasible, TORS should be considered the preferred surgical treatment in the salvage setting.
- 10 August 2022
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 114 (10) , 1400-1409
Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study
Background: Transoral robotic surgery (TORS) is an emerging minimally invasive surgical treatment for residual, recurrent, and new primary head and neck cancers in previously irradiated fields, with limited evidence for its oncological effectiveness. Methods: A retrospective observational cohort study of consecutive cases performed in 16 high-volume international centers before August 2018 was conducted (registered at clinicaltrials.gov [NCT04673929] as the RECUT study). Overall survival (OS), disease-free survival, disease-specific survivals (DSS), and local control (LC) were calculated using Kaplan-Meier estimates, with subgroups compared using log-rank tests and Cox proportional hazards modeling for multivariable analysis. Maximally selected rank statistics determined the cut point for closest surgical resection margin based on LC. Results: Data for 278 eligible patients were analyzed, with median follow-up of 38.5 months. Two-year and 5-year outcomes were 69.0% and 62.2% for LC, 71.8% and 49.8% for OS, 47.2% and 35.7% for disease-free survival, and 78.7% and 59.1% for disease-specific survivals. The most discriminating margin cut point was 1.0 mm; the 2-year LC was 80.9% above and 54.2% below or equal to 1.0 mm. Increasing age, current smoking, primary tumor classification, and narrow surgical margins (≤1.0 mm) were statistically significantly associated with lower OS. Hemorrhage with return to theater was seen in 8.1% (n = 22 of 272), and 30-day mortality was 1.8% (n = 5 of 272). At 1 year, 10.8% (n = 21 of 195) used tracheostomies, 33.8% (n = 66 of 195) used gastrostomies, and 66.3% (n = 53 of 80) had maintained or improved normalcy of diet scores. Conclusions: Data from international centers show TORS to treat head and neck cancers in previously irradiated fields yields favorable outcomes for LC and survival. Where feasible, TORS should be considered the preferred surgical treatment in the salvage setting.
- Open Access
- 7 May 2022
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 13 (4) , 696-701
Modified Preauricular Cervico-facial Approach for Oral Cancers: an Analysis of Oncological and Functional Outcomes
The quest for a more cosmetic and functionally better approach to oral cancer continues unabated. The modified facelift and preauricular approaches have been a common approach in trauma and cosmetic surgery. In the current study, we evaluate the feasibility and functional outcomes of a preauricular cervico-facial approach for compartmental resection of complex gingiva-buccal complex tumours with concurrent neck dissection. This was a prospective single-centre study and recruited patients of biopsy-proven operable advanced oral cavity tumours. These patients underwent compartmental tumour resections with neck dissection using the modified preauricular approach. Patients were followed up and advised adjuvant treatment when mandated. At 3rd month and 6th month follow-up, QoL was assessed using the self-administered University of Washington Quality of Life scale (UW-QOL). A total of 20 patients met the inclusion criteria and were recruited for the approach. All patients had surgically clear margins on histopathological analysis. Oral swallow was initiated on the 10th postoperative day and the average duration of nasogastric tube dependence was 13 days. All patients had reasonably good oral commissure competence and none had drooling of saliva at 6th month follow-up. Modified preauricular cervico-facial approach to locally advanced gingiva-buccal complex tumours is a safe and holds the possibility of a functionally superior approach.
- 7 May 2022
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 13 (4) , 696-701
Open AccessModified Preauricular Cervico-facial Approach for Oral Cancers: an Analysis of Oncological and Functional Outcomes
The quest for a more cosmetic and functionally better approach to oral cancer continues unabated. The modified facelift and preauricular approaches have been a common approach in trauma and cosmetic surgery. In the current study, we evaluate the feasibility and functional outcomes of a preauricular cervico-facial approach for compartmental resection of complex gingiva-buccal complex tumours with concurrent neck dissection. This was a prospective single-centre study and recruited patients of biopsy-proven operable advanced oral cavity tumours. These patients underwent compartmental tumour resections with neck dissection using the modified preauricular approach. Patients were followed up and advised adjuvant treatment when mandated. At 3rd month and 6th month follow-up, QoL was assessed using the self-administered University of Washington Quality of Life scale (UW-QOL). A total of 20 patients met the inclusion criteria and were recruited for the approach. All patients had surgically clear margins on histopathological analysis. Oral swallow was initiated on the 10th postoperative day and the average duration of nasogastric tube dependence was 13 days. All patients had reasonably good oral commissure competence and none had drooling of saliva at 6th month follow-up. Modified preauricular cervico-facial approach to locally advanced gingiva-buccal complex tumours is a safe and holds the possibility of a functionally superior approach.
- 22 April 2022
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 60 (7) , 1002-1003
Robotic neck dissection in head and neck cancer: a safe perception or deception?
- 22 April 2022
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 60 (7) , 1002-1003
Robotic neck dissection in head and neck cancer: a safe perception or deception?
- Open Access
- 1 January 2022
- Published by The Korean Association of Robotic Surgeons in Annals of Robotic and Innovative Surgery
- Vol. 3 (2) , 47-51
Self-Retaining Robotic Retractor in RAND Re-Visited (Ra-Vi Retractor)
Mishra S, et al. Ann Robot Innov Surg. 2022 Nov;3(2):47-51. https://doi.org/10.37007/aris.2022.3.2.47
- 1 January 2022
- Published by The Korean Association of Robotic Surgeons in Annals of Robotic and Innovative Surgery
- Vol. 3 (2) , 47-51
Open AccessSelf-Retaining Robotic Retractor in RAND Re-Visited (Ra-Vi Retractor)
Mishra S, et al. Ann Robot Innov Surg. 2022 Nov;3(2):47-51. https://doi.org/10.37007/aris.2022.3.2.47
- Open Access
- 1 January 2022
- Published by The Korean Association of Robotic Surgeons in Annals of Robotic and Innovative Surgery
- Vol. 3 (1) , 18-29
Swallowing Outcomes in Supraglottic Cancer Patients After Transoral Robotic Surgery With Early Dysphagia Management Using Standardized Functional and Objective Measures
Dabas SK, et al. Ann Robot Innov Surg. 2022 May;3(1):18-29. https://doi.org/10.37007/aris.2022.3.1.18
- 1 January 2022
- Published by The Korean Association of Robotic Surgeons in Annals of Robotic and Innovative Surgery
- Vol. 3 (1) , 18-29
Open AccessSwallowing Outcomes in Supraglottic Cancer Patients After Transoral Robotic Surgery With Early Dysphagia Management Using Standardized Functional and Objective Measures
Dabas SK, et al. Ann Robot Innov Surg. 2022 May;3(1):18-29. https://doi.org/10.37007/aris.2022.3.1.18
- 8 October 2021
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 278 (12) , 5107-5108
Sentinel node biopsy or elective neck dissection in early oral cancer: a point of contention
- 8 October 2021
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 278 (12) , 5107-5108
Sentinel node biopsy or elective neck dissection in early oral cancer: a point of contention
- 1 July 2021
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 12 (3) , 549-553
Role of Adjuvant Radiotherapy in Early Stage Tongue Cancer: Need for Establishing Stringent Guidelines
The primary objective of this study was to determine, using population-based data, whether the addition of postoperative radiotherapy (RT) provides an overall survival benefit in patients with early primary squamous cell carcinoma (SCC) of tongue. The study included the data of tongue cancer patients treated between January 2016 and July 2019 retrieved from our hospital database. Tumours limited to pathologic T1 and T2 category managed with primary surgery with or without postoperative external beam RT were included. Overall survival (OS) and disease-free survival (DFS) were the main outcomes of interest. A total of 211 cases of oral cancer were evaluated and all the patients had clear surgical and pathological margins. Postoperative adjuvant therapy (PORT) was received by 16 patients. Comparison of DFS and OS at 2-year follow-up depicted a similar outcome (p = 0.582 and p = 0.312 respectively). Findings from our study suggest that in the absence of any absolute advantage on quantifiable survival and disease control, it is necessary to define stringent criteria when advocating PORT in early tongue cancer.
- 1 July 2021
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 12 (3) , 549-553
Role of Adjuvant Radiotherapy in Early Stage Tongue Cancer: Need for Establishing Stringent Guidelines
The primary objective of this study was to determine, using population-based data, whether the addition of postoperative radiotherapy (RT) provides an overall survival benefit in patients with early primary squamous cell carcinoma (SCC) of tongue. The study included the data of tongue cancer patients treated between January 2016 and July 2019 retrieved from our hospital database. Tumours limited to pathologic T1 and T2 category managed with primary surgery with or without postoperative external beam RT were included. Overall survival (OS) and disease-free survival (DFS) were the main outcomes of interest. A total of 211 cases of oral cancer were evaluated and all the patients had clear surgical and pathological margins. Postoperative adjuvant therapy (PORT) was received by 16 patients. Comparison of DFS and OS at 2-year follow-up depicted a similar outcome (p = 0.582 and p = 0.312 respectively). Findings from our study suggest that in the absence of any absolute advantage on quantifiable survival and disease control, it is necessary to define stringent criteria when advocating PORT in early tongue cancer.
- 8 June 2021
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 13 (1) , 109-114
Residual Thyroid Tissue on Postoperative Diagnostic 131 I Radioactive Whole-Body Scan After Surgery in Differentiated Thyroid Cancer: A Tertiary Referral Centre Experience
Residual thyroid tissue after total thyroidectomy in differentiated thyroid cancers is considered an independent risk factor for recurrence. Guidelines recommend following up patients after surgery with thyroglobulin (Tg), neck ultrasonography, and occasionally whole-body radioactive scan. However, the results of serum thyroglobulin and whole-body radioiodine scan are often discordant. The present study was undertaken to determine the levels of serum-stimulated thyroglobulin to complement the findings of residual thyroid tissue in the radioactive whole-body scan. One hundred twenty-six patients had undergone a radioiodine (131 I) whole-body scan (WBS) during the study duration, and 121 were available for analysis. The thyroglobulin level (measured by the CLIA method) was recorded at the time of these scans. The data was analysed to determine the level of stimulated thyroglobulin correlating with residual thyroid tissue, locoregional, and distant metastasis as assessed by WBS. The presence of residual thyroid tissue was noted in an overwhelmingly high 94% of cases. Twenty-four of the 28 patients with stimulated Tg < 2 ng/dl had residual thyroid tissue on a WBS. The discordancy rate (positive moderate — large WBS and negative serum thyroglobulin) of 64.28% was seen. Using ROC the serum thyroglobulin cut-offs levels for the loco-regional disease were found to be 27.705 ng/dl and 94.770 ng/dl for distant metastasis. The results highlight the fact that serum Tg levels cannot be used as an accurate predictor of the extent of the remnant thyroid tissue. Irrespective of the quality of surgery, which was analysed based on the centre and surgical specialty, over 90% of cases had residual thyroid tissue on WBS. The use of only stimulated Tg levels for follow-up may be inaccurate. Serum Tg is a useful test along with radioactive whole-body scans to distinguish local disease, loco-regional disease, and distant metastasis.
- 8 June 2021
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 13 (1) , 109-114
Residual Thyroid Tissue on Postoperative Diagnostic 131 I Radioactive Whole-Body Scan After Surgery in Differentiated Thyroid Cancer: A Tertiary Referral Centre Experience
Residual thyroid tissue after total thyroidectomy in differentiated thyroid cancers is considered an independent risk factor for recurrence. Guidelines recommend following up patients after surgery with thyroglobulin (Tg), neck ultrasonography, and occasionally whole-body radioactive scan. However, the results of serum thyroglobulin and whole-body radioiodine scan are often discordant. The present study was undertaken to determine the levels of serum-stimulated thyroglobulin to complement the findings of residual thyroid tissue in the radioactive whole-body scan. One hundred twenty-six patients had undergone a radioiodine (131 I) whole-body scan (WBS) during the study duration, and 121 were available for analysis. The thyroglobulin level (measured by the CLIA method) was recorded at the time of these scans. The data was analysed to determine the level of stimulated thyroglobulin correlating with residual thyroid tissue, locoregional, and distant metastasis as assessed by WBS. The presence of residual thyroid tissue was noted in an overwhelmingly high 94% of cases. Twenty-four of the 28 patients with stimulated Tg < 2 ng/dl had residual thyroid tissue on a WBS. The discordancy rate (positive moderate — large WBS and negative serum thyroglobulin) of 64.28% was seen. Using ROC the serum thyroglobulin cut-offs levels for the loco-regional disease were found to be 27.705 ng/dl and 94.770 ng/dl for distant metastasis. The results highlight the fact that serum Tg levels cannot be used as an accurate predictor of the extent of the remnant thyroid tissue. Irrespective of the quality of surgery, which was analysed based on the centre and surgical specialty, over 90% of cases had residual thyroid tissue on WBS. The use of only stimulated Tg levels for follow-up may be inaccurate. Serum Tg is a useful test along with radioactive whole-body scans to distinguish local disease, loco-regional disease, and distant metastasis.